FLT3 internal tandem duplications in acute myeloid leukemia: mechanism of formation and clinical significance
- Authors: Itov A.B.1,2, Olshanskaya Y.V.1
-
Affiliations:
- The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
- The N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation
- Issue: Vol 24, No 1 (2025)
- Pages: 188-198
- Section: LITERATURE REVIEW
- Submitted: 29.01.2025
- Accepted: 25.02.2025
- Published: 08.07.2025
- URL: https://hemoncim.com/jour/article/view/951
- DOI: https://doi.org/10.24287/1726-1708-2025-24-1-188-198
- ID: 951
Cite item
Full Text
Abstract
This review presents the FLT3 gene structure and the working principle of the FLT3 protein coded by the gene, details the molecular mechanisms of FLT3 internal tandem duplication formation, the detailed structure and localization of tandem duplications in the FLT3 gene. Modern methods of FLT3-ITD diagnosis are described: fragment analysis, which provides an opportunity to estimate the allelic ratio, and next-generation sequencing, which allows for the study of the character of duplicated fragments and the localization of tandem duplications. This work presents the results of recent studies on the clinical significance of FLT3-ITD in acute myeloid leukemia with a normal karyotype and in the combination of FLT3-ITD with recurrent cytogenetic aberrations, as well as the results of studies showing the influence of the character of duplicated fragments and the location of FLT3-ITD insertion on survival rates. The main types of FLT3-inhibitors, their mechanism of action and clinical efficacy are described. Modern possibilities of FLT3-ITD monitoring and its practical significance for predicting the outcome of acute myeloid leukemia are presented.
Keywords
About the authors
A. B. Itov
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; The N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: albertitov03@gmail.com
ORCID iD: 0000-0003-0098-919X
Albert B. Itov - MD in Clinical Laboratory Medicine of the Laboratory of Cytogenetics and Molecular Genetics.
1 Samory Mashela St., 117997, Moscow
Russian FederationYu. V. Olshanskaya
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: Yuliya.Olshanskaya@dgoi.ru
ORCID iD: 0000-0002-2352-7716
Moscow
Russian FederationReferences
Supplementary files
